Clincosm LogoSign in Get a demo

Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

Sponsor
Yokohama City University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT01484158
Collaborator
(none)
450
Enrollment
134
Duration (Months)

Study Details

Study Description

Brief Summary

There are growing evidences that gait speed is inversely associated with all causes mortality especially cardiovascular mortality among the elderly. The purpose of this study is to evaluate the predictive value of gait speed for cardiovascular events in patients after ST-segment elevation myocardial infarction (STEMI).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The investigators will enroll patients capable of walking with STEMI. All patients will receive successful reperfusion therapy within 12-hour from onset. Gait speed during cardiac rehabilitation is measured. Cardiovascular events were defined as a composite of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, for an average follow-up period.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    450 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction
    Study Start Date :
    Oct 1, 2001
    Actual Primary Completion Date :
    Dec 1, 2012
    Actual Study Completion Date :
    Dec 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    Myocardial Infarction

    Patients with myocardial infarction

    Outcome Measures

    Primary Outcome Measures

    1. Cardiovascular Events [5 years]

      cardiovascular death, non-fatal myocardial infarction and non-fatal stroke

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Clinical diagnosis of ST-segment elevation acute myocardial infarction

    • Must be treated within 12 hours after symptom onset

    • Must be able to walk

    • Must receive successful primary percutaneous coronary intervention

    Exclusion Criteria:

    • History of prior myocardial infarction

    • Cerebrovascular disease with residual hemiplegia

    • Severe peripheral arterial disease

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Yokohama City University Medical Center

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yasushi Matsuzawa, Primary Investigator, Yokohama City University Medical Center
    ClinicalTrials.gov Identifier:
    NCT01484158
    Other Study ID Numbers:
    • Gait Speed Outcome Study
    First Posted:
    Dec 2, 2011
    Last Update Posted:
    Jan 22, 2015
    Last Verified:
    Jan 1, 2015
    Keywords provided by Yasushi Matsuzawa, Primary Investigator, Yokohama City University Medical Center
    Myocardial Infarction
    Additional relevant MeSH terms:
    Myocardial Infarction
    Infarction

    Study Results

    No Results Posted as of Jan 22, 2015